Skip Navigation


Annals of Oncology Advance Access originally published online on March 5, 2008
Annals of Oncology 2008 19(5):831-833; doi:10.1093/annonc/mdn034
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/5/831    most recent
mdn034v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ali, R.
Right arrow Articles by Raina, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ali, R.
Right arrow Articles by Raina, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

editorials

Developing innovative models for North–South cooperation in clinical research—experience from the INDOX Cancer Research Network

R. Ali1,* and V. Raina2

1 INDOX Cancer Research Network, & Department of Clinical Pharmacology, University of Oxford, Oxford, UK
2 Department of Medical Oncology & Delhi Cancer Registry Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India

* (E-mail: raghib.ali@clinpharm.ox.ac.uk)

The first 150 words of the full text of this article appear below.

Cancer, long thought of as a disease of richer, industrialised and high-income nations, is now the second leading cause of death in many lower income countries. More than 50% of the world's cancer burden, in terms of both numbers of cases and deaths, occurs in developing countries and is rising [1]. More particularly, some 45% of >1 million new cases of breast cancer diagnosed each year and >55% of breast cancer-related deaths occur in low- and middle-income countries [2, 3]. By 2020 it is estimated that 70% of all cancer cases will be in these lower income countries—and approximately one-quarter of these will be in India, with its (still increasing) population of over a billion [1].

India is experiencing rapid demographic, socioeconomic and risk factor changes, particularly in urban areas, leading to an alarming rise in the incidence of chronic diseases such as . . . [Full Text of this Article]

progress to date

ethical concerns

future plans

conclusions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
J. B. Vermorken
Annals of Oncology: some modest proposals but some great aims
Ann. Onc., August 1, 2009; 20(8): 1289 - 1290.
[Full Text] [PDF]